SITC
November 15, 2021
Society for Immunotherapy of Cancer’s (SITC) 36th Anniversary Annual Meeting, November 11-14, 2021
Year
2021
Target
STING, HPK1
Assets in this page
Download assets
- pdf file
"Novel, orally administered HPK1 inhibitors demonstrate anti-tumor efficacy and enhanced immune response"
Download - pdf file
"Characterization of RVU-27065 a novel small-molecule STING agonist suitable for systemic administration"
Download